Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting. (2018)
Attributed to:
Imperial Confidence in Concept: ICiC5
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2018.08.017
PubMed Identifier: 30300581
Publication URI: http://europepmc.org/abstract/MED/30300581
Type: Journal Article/Review
Volume: 34
Parent Publication: Cancer cell
Issue: 4
ISSN: 1535-6108